BM

Bruce Meiklejohn

Vice President, Chemistry, Manufacturing and Controls at Omeros

Dr. Meiklejohn joined Omeros as our vice president, chemistry, manufacturing and controls (CMC) in October 2019. Prior to joining Omeros in this role, Dr. Meiklejohn was an expert CMC consultant for several biotechnology companies, including Omeros. His consulting work followed a distinguished career at Eli Lilly and Company, where he held a number of CMC leadership roles including head of Lilly’s biopharmaceutical product development division and senior research fellow in regulatory affairs CMC. While at Lilly, Dr. Meiklejohn led or played a key role in CMC activities for a number of multibillion-dollar drugs, including Trulicity®, Cialis®, Alimta®, Forteo®, and Cymbalta®. An internationally recognized leader in biotechnology manufacturing, Dr. Meiklejohn has helped shape regulatory policy for biotechnology products. Dr. Meiklejohn received his PhD in analytical chemistry, as well as BS degrees in Biology and Chemistry, from Colorado State University.

Timeline

  • Vice President, Chemistry, Manufacturing and Controls

    Current role

View in org chart